SUBSCRIBE
SUBSCRIBE

Mural Oncology

NEWS
3D illustration of a T cell killing a cancer cell
Opinion
Ten Years After a Seminal Approval, Immuno-oncology Is Poised for the Next Revolution
While some of the initial excitement around immunotherapies has waned, companies—particularly smaller biotechs—are developing newer iterations that will take cancer care to the next level.
November 4, 2024
 · 
4 min read
 · 
Caroline Loew
IN THE PRESS
Press Releases
Mural Oncology Announces Third Quarter 2024 Financial Results and Provides Update on Pipeline Progress
November 13, 2024
 · 
12 min read
Press Releases
Mural Oncology to Participate in Two Upcoming Investor Conferences
November 11, 2024
 · 
1 min read
Press Releases
Mural Oncology Presents Clinical and Preclinical Data Across its Pipeline at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
November 8, 2024
 · 
10 min read
Press Releases
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 4, 2024
 · 
2 min read
Press Releases
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - July 2, 2024
October 21, 2024
 · 
2 min read
Press Releases
Mural Oncology to Present Clinical and Preclinical Data at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
October 8, 2024
 · 
6 min read
Press Releases
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - October 2, 2024
October 3, 2024
 · 
2 min read
Press Releases
Mural Oncology’s First Virtual Investor Day to Highlight Late-Stage Clinical Progress
September 27, 2024
 · 
11 min read
Press Releases
Mural Oncology Strengthens Board of Directors with the Appointment of Sachiyo Minegishi
September 24, 2024
 · 
5 min read
Press Releases
Mural Oncology to Host First Virtual Investor Day on September 26, 2024
September 10, 2024
 · 
6 min read
Load More
JOBS